Media Watch: drug maker under scrutiny

By 2008-03-13T09:00:00

Being accused of 'cheating the NHS' is enough to give anyone heartburn. So bosses at Reckitt Benckiser, makers of indigestion treatment Gaviscon, may well have sought comfort with a taste of their own medicine this week.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here